Recent developments of pharmacogenomics in the treatment of colorectal cancers

Annales pharmaceutiques françaises
A Astier

Abstract

Colorectal cancer (CCR), which is one of the most common causes of cancer, has benefited from the major advances in the understanding of the intracellular signaling pathways implicated in the initiation, growing and local and metastasis dissemination of tumor, which have occurred during the 20 past years. The pharmacogenomics approach, especially the determination of the genetic polymorphisms, tries to find prognosis and predictive biomarkers permitting to identify patients who could benefit from a particular treatment or those exhibiting higher risks of toxicity. Among the numerous biomarkers, which have been studied, few are currently in use in clinical practice. The phenotyping of DPD and UGT1A1 activities, and to a lesser extent, its genotyping, appears as the most useful tool in terms of prediction of toxicities induced by two major drugs: 5-FU and irinotecan. For oxaliplatin, the determination of the polymorphisms of reparases and detoxification systems such as GSTpi seems interesting, but its exact place should be more defined. It is in the field of targeted therapies that the pharmacogenomics approach seems to be the more relevant. KRAS mutation is a dramatic example of single nucleotide polymorphism, which is able to i...Continue Reading

References

Dec 5, 1996·The New England Journal of Medicine·D ShibataI C Summerhayes
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G Milano, H L McLeod
May 23, 2002·International Journal of Colorectal Disease·David J ParkHeinz-Josef Lenz
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·André B P Van KuilenburgAlbert H Van Gennip
Dec 14, 2002·Analytical Biochemistry·Benoît BlanchetAlain Astier
May 6, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Alex SparreboomWilliam D Figg
Apr 23, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lori K MattisonRobert B Diasio
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Jul 31, 2004·Science·Raffaella SordellaJeffrey Settleman
Oct 12, 2004·Genomics·Sharon MarshHoward L McLeod
Nov 10, 2004·The Pharmacogenomics Journal·C R KingS Marsh
Dec 18, 2004·Onkologie·Wan-Teck Lim, Howard L McLeod
Jul 20, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Gaëlle RemaudErick Gamelin
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Katharina SeckEva Gross
Sep 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuji OginoCharles S Fuchs
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe ToffoliSergio Frustaci
Sep 20, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Chikako KiyoharaYoichi Nakanishi
Dec 14, 2006·Cancer Chemotherapy and Pharmacology·M W SaifRobert B Diasio
Dec 7, 2007·Drug Discovery Today·Jan PanderHenk-Jan Guchelaar
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Mar 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rafael G AmadoDavid D Chang
Mar 14, 2008·The New England Journal of Medicine·Fortunato Ciardiello, Giampaolo Tortora
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federica Di NicolantonioAlberto Bardelli
Dec 23, 2008·Advanced Drug Delivery Reviews·Alexandra PohlHeinz-Josef Lenz
Apr 8, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federico InnocentiMark J Ratain
May 12, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gaëtan Des GuetzBernard Uzzan
Jun 2, 2009·Nature Reviews. Clinical Oncology·Rakesh K JainA Gregory Sorensen
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bryan P SchneiderKathy D Miller
Sep 17, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jerry Y Hsu, Heather A Wakelee
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe ToffoliFederico Innocenti
Jan 15, 2010·Indian Journal of Cancer·M N Sadananda AdigaL Krishnamoorthy
Feb 24, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Frédéric HollandeDominique Joubert
Jun 30, 2010·Breast Cancer Research : BCR·Xiaowei QiJun Jiang

❮ Previous
Next ❯

Citations

Dec 12, 2019·Frontiers in Pharmacology·Suhong YuLee Jia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Critical Reviews in Oncology/hematology
Javier RodríguezIgnacio Gil-Bazo
Therapeutic Advances in Gastroenterology
Sing Yu MoorcraftDavid Cunningham
Annals of Oncology : Official Journal of the European Society for Medical Oncology
G CereaSalvatore Siena
Expert Opinion on Emerging Drugs
David R FogelmanCathy Eng
© 2021 Meta ULC. All rights reserved